MRNA
NASDAQ · Biotechnology
Moderna Inc
$59.35
-4.62 (-7.22%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+90.21%
1Y
+131.18%
YTD
+92.30%
Open$64.07
Previous Close$63.96
Day High$65.51
Day Low$57.50
52W High$67.74
52W Low$22.28
Volume—
Avg Volume8.66M
Market Cap25.38B
P/E Ratio—
EPS$-8.15
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$37.98
Above
SMA 200
$29.64
Above
RSI (14)
57.2
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
30 analysts
Price Target
+151.8% upside
Current
$59.35
$59.35
Target
$149.45
$149.45
$89.97
$149.45 avg
$212.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.98B | 4.26B | 2.23B |
| Net Income | -2,878,486,015 | -5,564,083,791 | -285,156,561 |
| Profit Margin | -145.2% | -137.9% | -12.8% |
| EBITDA | -2,916,220,389 | -5,950,191,944 | -355,384,473 |
| Free Cash Flow | — | — | -237,052,091 |
| Rev Growth | -53.4% | -53.4% | +3.0% |
| Debt/Equity | 0.07 | 0.07 | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |